International pharma specialists meet at Bosch
Representatives of AbbVie, Eli Lilly, NNE Pharmaplan, Roche Diagnostics and Vetter Pharma reported on unusual projects, current challenges and future trends, such as filling of highly potent pharmaceuticals and innovative approaches for the development of parenteral dosage forms.
Connected industry and its opportunities for pharmaceutical production — 300 international pharma experts discussed this topic from 10 to 11 May in Crailsheim, Germany. “Pharmatag”, hosted by the division Packaging Technology, took place for the eighth time. With 50% more guests from the pharmaceutical, biopharmaceutical and process technology industries, the symposium achieved record attendance. “Pharmatag 2016 offered the 300 participants from all over the world a versatile mix of lectures, podium discussion and new technologies,” said Joachim Brenner, general manager at Bosch Packaging Technology in Crailsheim. “The growing number of participants of this triannual event shows that Bosch Packaging Technology plays a leading role in the pharmaceutical industry and the high customer demand for events like this.”
Focus on pharmaceutical line competence
On day one, the guests of Pharmatag had the opportunity to look behind the scenes of the Crailsheim production facility and to receive first-hand information about Bosch's pharmaceutical line competence as well as current portfolio expansions. A special highlight was the launch of the new ALF 5000 filling and closing machine for ampoules and injection bottles. Apart from an output of 600 containers per minute, the machine features high flexibility and process safety.
The second day with lectures and a podium discussion was opened by Friedbert Klefenz, President of Bosch Packaging Technology. In his key note speech, Prof. Thomas Bauernhansl, head of the Fraunhofer Institute for Manufacturing Engineering and Automation, and the Institute of Industrial Manufacturing and Management at the University of Stuttgart, gave insights into the opportunities of industry 4.0, as well as an outlook on the future of pharmaceutical production.
Representatives of AbbVie, Eli Lilly, NNE Pharmaplan, Roche Diagnostics and Vetter Pharma reported on unusual projects, current challenges and future trends, such as filling of highly potent pharmaceuticals and innovative approaches for the development of parenteral dosage forms. The subsequent podium discussion addressed quality, flexibility and industry 4.0 in pharmaceutical manufacturing. Claudia Petersen, Global Director Business Development at Gerresheimer, led through the program.
CPI software for connected serialization
Apart from numerous filling machines and lines for liquid pharmaceuticals, the participants also received information about exterior washing of vials and ampoules (RAN 3080), the combination of visual inspection technology and leak detection (AIM 3000), matching downstream equipment (RIL 3010), as well as special customer projects. Secondary packaging and serialization solutions completed the presentation of Bosch's pharmaceutical line competence.
Moreover, Bosch showcased further industry 4.0 application possibilities for the pharmaceutical industry. Combined with the CPI software from Bosch, Track & Trace solutions can be integrated into the company IT in a multi-level process. This way, manufacturers are not only able to process the entire order management; they also control both import and export of the serial numbers. All relevant data is available in the company network and can be transferred to regulatory or company-owned databases according to regulatory requirements.
A further important part of Bosch's line competence consists in after-sales services, which support customers in flexibly adapting their existing equipment to future market requirements.
General manager Joachim Brenner was satisfied with the outcome of Pharmatag 2016: “Not long ago, we hosted the Meet & Match event of BIOPRO Baden-Württemberg, and for the last two days we welcomed representatives of the leading international pharmaceutical companies. This shows the importance of the Bosch Packaging Technology site in Crailsheim for the industry — regionally and internationally.”
Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance